Related Experiment Video

Updated: Jun 18, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Tyrphostin ErbB2 Inhibitors AG825 and AG879 Have Non-specific Suppressive Effects on gp130/ STAT3 Signaling

Hyun Kyoung Lee1, In Ae Seo, Sang Hwa Lee

  • 1Department of Physiology, Medical Science Research Institute, College of Medicine, Dong-A University, Busan 602-714, Korea.

The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology
|December 8, 2009
PubMed

Insights

Specific tyrphostin inhibitors targeting ErbB2 suppressed IL-6 signaling in schwannoma cells. However, this effect was not due to direct ErbB2 transactivation, suggesting potential off-target actions of these inhibitors on the IL-6/STAT3 pathway.

Area of Science:

  • Cellular signaling pathways
  • Cancer biology
  • Molecular mechanisms

Background:

  • The interaction between gp130 and the ErbB family is implicated in cancer.
  • The precise mechanism of this interaction remains poorly understood and debated.

Purpose of the Study:

  • To investigate the mechanism of IL-6/STAT3 pathway modulation by ErbB family inhibitors.
  • To clarify the role of ErbB2 in IL-6-induced STAT3 phosphorylation in schwannoma cells.

Main Methods:

  • Utilized specific tyrphostin inhibitors (AG825, AG879, AG1478) targeting ErbB family members.
  • Employed RNA interference (RNAi) to inhibit ErbB2 expression.
  • Transfected cells with an ErbB2 mutant lacking its intracellular domain.
  • Assessed IL-6-induced tyrosine phosphorylation of STAT3.

Main Results:

  • ErbB2-specific tyrphostins (AG825, AG879) inhibited IL-6-induced STAT3 phosphorylation in schwannoma cells.
  • IL-6 did not biochemically transactivate ErbB2.
  • Inhibition of ErbB2 expression or function did not affect IL-6-induced STAT3 phosphorylation.

Conclusions:

  • Tyrphostins targeting ErbB2 may exert non-specific suppressive effects on the IL-6/STAT3 pathway.
  • The observed inhibition is likely not mediated by direct transactivation or functional inhibition of ErbB2.
Keywords:
ErbB2 kinaseInterleukin-6NeuregulinSTAT3Schwannomagp130

More Related Videos

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery08:38

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery

Published on: October 4, 2018

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...